Find out how AI influences drug discovery, enabling earlier predictions and reducing the risks in clinical development.

The collaboration marks a turning point in AI-driven drug design and trial forecasting, de-risking the drug development ...

Insilico Medicine, a clinical-stage biotechnology company powered by generative AI, and Qilu Pharmaceutical Group, a major comprehensive modern pharmaceutical enterprise in China, as well as its ...

The potential of using artificial intelligence in drug discovery and development has sparked both excitement and skepticism among scientists, investors, and the general public. Researchers have ...

Since 1995, Nature Medicine has been chronicling advances in medical technology and health care. To mark the journal’s 30th anniversary, each month an issue of critical importance for the future of ...

Meanwhile, a total of 76 innovative medical devices, of which 80 percent were domestically developed, were granted market ...

Altasciences, a fully integrated drug development solution company, and VoxCell BioInnovation (“VoxCell”), a leader in 3D bioprinting and human-like tissue modeling, are pleased to announce a ...

Stability is a critical factor in drug formulation, with implications for product quality, lifecycle management, and ...

A new analysis of drug trials used to approve medicines in the United States shows how far modern medicine still has to go to ...